231 related articles for article (PubMed ID: 11960600)
1. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
2. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
3. Ginkgolide B stimulates signaling events in neutrophils and primes defense activities.
Lenoir M; Muntaner O; Pedruzzi E; Roch-Arveiller M; Tissot M; Drieu K; Périanin A
Biochem Biophys Res Commun; 2005 Oct; 335(4):1149-54. PubMed ID: 16122706
[TBL] [Abstract][Full Text] [Related]
4. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo biloba extract EGb 761 and isolated ginkgolide B.
Amri H; Drieu K; Papadopoulos V
Endocrinology; 1997 Dec; 138(12):5415-26. PubMed ID: 9389527
[TBL] [Abstract][Full Text] [Related]
6. Mechanism and regulation of neutrophil priming by platelet-activating factor.
Gay JC
J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
[TBL] [Abstract][Full Text] [Related]
7. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
9. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
11. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.
Kondratskaya EL; Pankratov YV; Lalo UV; Chatterjee SS; Krishtal OA
Neurochem Int; 2004 Feb; 44(3):171-7. PubMed ID: 14568560
[TBL] [Abstract][Full Text] [Related]
14. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation.
Strømgaard K; Saito DR; Shindou H; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2002 Aug; 45(18):4038-46. PubMed ID: 12190325
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
Chatterjee SS; Kondratskaya EL; Krishtal OA
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
[TBL] [Abstract][Full Text] [Related]
17. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion.
Kotelevets L; Noë V; Bruyneel E; Myssiakine E; Chastre E; Mareel M; Gespach C
J Biol Chem; 1998 Jun; 273(23):14138-45. PubMed ID: 9603913
[TBL] [Abstract][Full Text] [Related]
20. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
